Global Migraine Therapeutics Market Size, Status and Forecast 2024-2031

Report ID: 920397 | Published Date: Jan 2025 | No. of Page: 127 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Migraine Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Specific Anti-migraine Drugs
        1.2.3 Acute Therapies
        1.2.4 Preventative Therapies
        1.2.5 Other
    1.3 Market by Application
        1.3.1 Global Migraine Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Household Use
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Migraine Therapeutics Market Perspective (2016-2027)
    2.2 Migraine Therapeutics Growth Trends by Regions
        2.2.1 Migraine Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Migraine Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 Migraine Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 Migraine Therapeutics Industry Dynamic
        2.3.1 Migraine Therapeutics Market Trends
        2.3.2 Migraine Therapeutics Market Drivers
        2.3.3 Migraine Therapeutics Market Challenges
        2.3.4 Migraine Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Migraine Therapeutics Players by Revenue
        3.1.1 Global Top Migraine Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global Migraine Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global Migraine Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Migraine Therapeutics Revenue
    3.4 Global Migraine Therapeutics Market Concentration Ratio
        3.4.1 Global Migraine Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Migraine Therapeutics Revenue in 2020
    3.5 Migraine Therapeutics Key Players Head office and Area Served
    3.6 Key Players Migraine Therapeutics Product Solution and Service
    3.7 Date of Enter into Migraine Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Migraine Therapeutics Breakdown Data by Type
    4.1 Global Migraine Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global Migraine Therapeutics Forecasted Market Size by Type (2022-2027)

5 Migraine Therapeutics Breakdown Data by Application
    5.1 Global Migraine Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global Migraine Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Migraine Therapeutics Market Size (2016-2027)
    6.2 North America Migraine Therapeutics Market Size by Type
        6.2.1 North America Migraine Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America Migraine Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America Migraine Therapeutics Market Size by Type (2016-2027)
    6.3 North America Migraine Therapeutics Market Size by Application
        6.3.1 North America Migraine Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America Migraine Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America Migraine Therapeutics Market Size by Application (2016-2027)
    6.4 North America Migraine Therapeutics Market Size by Country
        6.4.1 North America Migraine Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America Migraine Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Migraine Therapeutics Market Size (2016-2027)
    7.2 Europe Migraine Therapeutics Market Size by Type
        7.2.1 Europe Migraine Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe Migraine Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe Migraine Therapeutics Market Size by Type (2016-2027)
    7.3 Europe Migraine Therapeutics Market Size by Application
        7.3.1 Europe Migraine Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe Migraine Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe Migraine Therapeutics Market Size by Application (2016-2027)
    7.4 Europe Migraine Therapeutics Market Size by Country
        7.4.1 Europe Migraine Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe Migraine Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Migraine Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific Migraine Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Migraine Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Migraine Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Migraine Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Migraine Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Migraine Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Migraine Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Migraine Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Migraine Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Migraine Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Migraine Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Migraine Therapeutics Market Size (2016-2027)
    9.2 Latin America Migraine Therapeutics Market Size by Type
        9.2.1 Latin America Migraine Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America Migraine Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America Migraine Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America Migraine Therapeutics Market Size by Application
        9.3.1 Latin America Migraine Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America Migraine Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America Migraine Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America Migraine Therapeutics Market Size by Country
        9.4.1 Latin America Migraine Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America Migraine Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Migraine Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa Migraine Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Migraine Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Migraine Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Migraine Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Migraine Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Migraine Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Migraine Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Migraine Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Migraine Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Migraine Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Migraine Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Allergan
        11.1.1 Allergan Company Details
        11.1.2 Allergan Business Overview
        11.1.3 Allergan Migraine Therapeutics Introduction
        11.1.4 Allergan Revenue in Migraine Therapeutics Business (2016-2021)
        11.1.5 Allergan Recent Development
    11.2 Merck
        11.2.1 Merck Company Details
        11.2.2 Merck Business Overview
        11.2.3 Merck Migraine Therapeutics Introduction
        11.2.4 Merck Revenue in Migraine Therapeutics Business (2016-2021)
        11.2.5 Merck Recent Development
    11.3 Pfizer
        11.3.1 Pfizer Company Details
        11.3.2 Pfizer Business Overview
        11.3.3 Pfizer Migraine Therapeutics Introduction
        11.3.4 Pfizer Revenue in Migraine Therapeutics Business (2016-2021)
        11.3.5 Pfizer Recent Development
    11.4 Teva
        11.4.1 Teva Company Details
        11.4.2 Teva Business Overview
        11.4.3 Teva Migraine Therapeutics Introduction
        11.4.4 Teva Revenue in Migraine Therapeutics Business (2016-2021)
        11.4.5 Teva Recent Development
    11.5 Amgen
        11.5.1 Amgen Company Details
        11.5.2 Amgen Business Overview
        11.5.3 Amgen Migraine Therapeutics Introduction
        11.5.4 Amgen Revenue in Migraine Therapeutics Business (2016-2021)
        11.5.5 Amgen Recent Development
    11.6 Johnson & Johnson
        11.6.1 Johnson & Johnson Company Details
        11.6.2 Johnson & Johnson Business Overview
        11.6.3 Johnson & Johnson Migraine Therapeutics Introduction
        11.6.4 Johnson & Johnson Revenue in Migraine Therapeutics Business (2016-2021)
        11.6.5 Johnson & Johnson Recent Development
    11.7 Endo International
        11.7.1 Endo International Company Details
        11.7.2 Endo International Business Overview
        11.7.3 Endo International Migraine Therapeutics Introduction
        11.7.4 Endo International Revenue in Migraine Therapeutics Business (2016-2021)
        11.7.5 Endo International Recent Development
    11.8 GlaxoSmithKline
        11.8.1 GlaxoSmithKline Company Details
        11.8.2 GlaxoSmithKline Business Overview
        11.8.3 GlaxoSmithKline Migraine Therapeutics Introduction
        11.8.4 GlaxoSmithKline Revenue in Migraine Therapeutics Business (2016-2021)
        11.8.5 GlaxoSmithKline Recent Development
    11.9 Impax
        11.9.1 Impax Company Details
        11.9.2 Impax Business Overview
        11.9.3 Impax Migraine Therapeutics Introduction
        11.9.4 Impax Revenue in Migraine Therapeutics Business (2016-2021)
        11.9.5 Impax Recent Development
    11.10 Abbott
        11.10.1 Abbott Company Details
        11.10.2 Abbott Business Overview
        11.10.3 Abbott Migraine Therapeutics Introduction
        11.10.4 Abbott Revenue in Migraine Therapeutics Business (2016-2021)
        11.10.5 Abbott Recent Development
    11.11 Bayer
        11.11.1 Bayer Company Details
        11.11.2 Bayer Business Overview
        11.11.3 Bayer Migraine Therapeutics Introduction
        11.11.4 Bayer Revenue in Migraine Therapeutics Business (2016-2021)
        11.11.5 Bayer Recent Development
    11.12 Eli Lilly
        11.12.1 Eli Lilly Company Details
        11.12.2 Eli Lilly Business Overview
        11.12.3 Eli Lilly Migraine Therapeutics Introduction
        11.12.4 Eli Lilly Revenue in Migraine Therapeutics Business (2016-2021)
        11.12.5 Eli Lilly Recent Development
    11.13 Novartis International
        11.13.1 Novartis International Company Details
        11.13.2 Novartis International Business Overview
        11.13.3 Novartis International Migraine Therapeutics Introduction
        11.13.4 Novartis International Revenue in Migraine Therapeutics Business (2016-2021)
        11.13.5 Novartis International Recent Development
    11.14 Ethypharm
        11.14.1 Ethypharm Company Details
        11.14.2 Ethypharm Business Overview
        11.14.3 Ethypharm Migraine Therapeutics Introduction
        11.14.4 Ethypharm Revenue in Migraine Therapeutics Business (2016-2021)
        11.14.5 Ethypharm Recent Development
    11.15 Kowa Pharmaceuticals America
        11.15.1 Kowa Pharmaceuticals America Company Details
        11.15.2 Kowa Pharmaceuticals America Business Overview
        11.15.3 Kowa Pharmaceuticals America Migraine Therapeutics Introduction
        11.15.4 Kowa Pharmaceuticals America Revenue in Migraine Therapeutics Business (2016-2021)
        11.15.5 Kowa Pharmaceuticals America Recent Development
    11.16 Winston Pharmaceuticals
        11.16.1 Winston Pharmaceuticals Company Details
        11.16.2 Winston Pharmaceuticals Business Overview
        11.16.3 Winston Pharmaceuticals Migraine Therapeutics Introduction
        11.16.4 Winston Pharmaceuticals Revenue in Migraine Therapeutics Business (2016-2021)
        11.16.5 Winston Pharmaceuticals Recent Development
    11.17 AstraZeneca
        11.17.1 AstraZeneca Company Details
        11.17.2 AstraZeneca Business Overview
        11.17.3 AstraZeneca Migraine Therapeutics Introduction
        11.17.4 AstraZeneca Revenue in Migraine Therapeutics Business (2016-2021)
        11.17.5 AstraZeneca Recent Development
    11.18 Amirall
        11.18.1 Amirall Company Details
        11.18.2 Amirall Business Overview
        11.18.3 Amirall Migraine Therapeutics Introduction
        11.18.4 Amirall Revenue in Migraine Therapeutics Business (2016-2021)
        11.18.5 Amirall Recent Development
    11.18 OptiNose
        11.25.1 OptiNose Company Details
        11.25.2 OptiNose Business Overview
        11.25.3 OptiNose Migraine Therapeutics Introduction
        11.25.4 OptiNose Revenue in Migraine Therapeutics Business (2016-2021)
        11.25.5 OptiNose Recent Development
    11.20 Revance Therapeutics
        11.20.1 Revance Therapeutics Company Details
        11.20.2 Revance Therapeutics Business Overview
        11.20.3 Revance Therapeutics Migraine Therapeutics Introduction
        11.20.4 Revance Therapeutics Revenue in Migraine Therapeutics Business (2016-2021)
        11.20.5 Revance Therapeutics Recent Development
    11.21 RedHill Biopharma
        11.21.1 RedHill Biopharma Company Details
        11.21.2 RedHill Biopharma Business Overview
        11.21.3 RedHill Biopharma Migraine Therapeutics Introduction
        11.21.4 RedHill Biopharma Revenue in Migraine Therapeutics Business (2016-2021)
        11.21.5 RedHill Biopharma Recent Development
    11.22 Bausch Health
        11.22.1 Bausch Health Company Details
        11.22.2 Bausch Health Business Overview
        11.22.3 Bausch Health Migraine Therapeutics Introduction
        11.22.4 Bausch Health Revenue in Migraine Therapeutics Business (2016-2021)
        11.22.5 Bausch Health Recent Development
    11.23 NeurAxon
        11.23.1 NeurAxon Company Details
        11.23.2 NeurAxon Business Overview
        11.23.3 NeurAxon Migraine Therapeutics Introduction
        11.23.4 NeurAxon Revenue in Migraine Therapeutics Business (2016-2021)
        11.23.5 NeurAxon Recent Development
    11.24 Biohaven Pharma
        11.24.1 Biohaven Pharma Company Details
        11.24.2 Biohaven Pharma Business Overview
        11.24.3 Biohaven Pharma Migraine Therapeutics Introduction
        11.24.4 Biohaven Pharma Revenue in Migraine Therapeutics Business (2016-2021)
        11.24.5 Biohaven Pharma Recent Development
    11.25 Eisai
        11.25.1 Eisai Company Details
        11.25.2 Eisai Business Overview
        11.25.3 Eisai Migraine Therapeutics Introduction
        11.25.4 Eisai Revenue in Migraine Therapeutics Business (2016-2021)
        11.25.5 Eisai Recent Development
    11.26 Valeant Pharma
        11.26.1 Valeant Pharma Company Details
        11.26.2 Valeant Pharma Business Overview
        11.26.3 Valeant Pharma Migraine Therapeutics Introduction
        11.26.4 Valeant Pharma Revenue in Migraine Therapeutics Business (2016-2021)
        11.26.5 Valeant Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Migraine Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Specific Anti-migraine Drugs
    Table 3. Key Players of Acute Therapies
    Table 4. Key Players of Preventative Therapies
    Table 5. Key Players of Other
    Table 6. Global Migraine Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Migraine Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Migraine Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Migraine Therapeutics Market Share by Regions (2016-2021)
    Table 10. Global Migraine Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Migraine Therapeutics Market Share by Regions (2022-2027)
    Table 12. Migraine Therapeutics Market Trends
    Table 13. Migraine Therapeutics Market Drivers
    Table 14. Migraine Therapeutics Market Challenges
    Table 15. Migraine Therapeutics Market Restraints
    Table 16. Global Migraine Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Migraine Therapeutics Market Share by Players (2016-2021)
    Table 18. Global Top Migraine Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Migraine Therapeutics as of 2020)
    Table 19. Ranking of Global Top Migraine Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Migraine Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Migraine Therapeutics Product Solution and Service
    Table 23. Date of Enter into Migraine Therapeutics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Migraine Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Migraine Therapeutics Revenue Market Share by Type (2016-2021)
    Table 27. Global Migraine Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Migraine Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Migraine Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Migraine Therapeutics Revenue Market Share by Application (2016-2021)
    Table 31. Global Migraine Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Migraine Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Migraine Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Migraine Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Migraine Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Migraine Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Migraine Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Migraine Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Migraine Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Migraine Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Migraine Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Migraine Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Migraine Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Migraine Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Migraine Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Migraine Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Migraine Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Migraine Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Migraine Therapeutics Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Migraine Therapeutics Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Migraine Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Migraine Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Migraine Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Migraine Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Migraine Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Migraine Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Migraine Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Migraine Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Migraine Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Migraine Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Migraine Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Migraine Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Allergan Company Details
    Table 64. Allergan Business Overview
    Table 65. Allergan Migraine Therapeutics Product
    Table 66. Allergan Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 67. Allergan Recent Development
    Table 68. Merck Company Details
    Table 69. Merck Business Overview
    Table 70. Merck Migraine Therapeutics Product
    Table 71. Merck Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 72. Merck Recent Development
    Table 73. Pfizer Company Details
    Table 74. Pfizer Business Overview
    Table 75. Pfizer Migraine Therapeutics Product
    Table 76. Pfizer Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 77. Pfizer Recent Development
    Table 78. Teva Company Details
    Table 79. Teva Business Overview
    Table 80. Teva Migraine Therapeutics Product
    Table 81. Teva Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 82. Teva Recent Development
    Table 83. Amgen Company Details
    Table 84. Amgen Business Overview
    Table 85. Amgen Migraine Therapeutics Product
    Table 86. Amgen Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 87. Amgen Recent Development
    Table 88. Johnson & Johnson Company Details
    Table 89. Johnson & Johnson Business Overview
    Table 90. Johnson & Johnson Migraine Therapeutics Product
    Table 91. Johnson & Johnson Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 92. Johnson & Johnson Recent Development
    Table 93. Endo International Company Details
    Table 94. Endo International Business Overview
    Table 95. Endo International Migraine Therapeutics Product
    Table 96. Endo International Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 97. Endo International Recent Development
    Table 98. GlaxoSmithKline Company Details
    Table 99. GlaxoSmithKline Business Overview
    Table 100. GlaxoSmithKline Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 101. GlaxoSmithKline Recent Development
    Table 102. Impax Company Details
    Table 103. Impax Business Overview
    Table 104. Impax Migraine Therapeutics Product
    Table 105. Impax Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 106. Impax Recent Development
    Table 107. Abbott Company Details
    Table 108. Abbott Business Overview
    Table 109. Abbott Migraine Therapeutics Product
    Table 110. Abbott Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 111. Abbott Recent Development
    Table 112. Bayer Company Details
    Table 113. Bayer Business Overview
    Table 114. Bayer Migraine Therapeutics Product
    Table 115. Bayer Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 116. Bayer Recent Development
    Table 117. Eli Lilly Company Details
    Table 118. Eli Lilly Business Overview
    Table 119. Eli Lilly Migraine Therapeutics Product
    Table 120. Eli Lilly Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 121. Eli Lilly Recent Development
    Table 122. Novartis International Company Details
    Table 123. Novartis International Business Overview
    Table 124. Novartis International Migraine Therapeutics Product
    Table 125. Novartis International Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 126. Novartis International Recent Development
    Table 127. Ethypharm Company Details
    Table 128. Ethypharm Business Overview
    Table 129. Ethypharm Migraine Therapeutics Product
    Table 130. Ethypharm Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 131. Ethypharm Recent Development
    Table 132. Kowa Pharmaceuticals America Company Details
    Table 133. Kowa Pharmaceuticals America Business Overview
    Table 134. Kowa Pharmaceuticals America Migraine Therapeutics Product
    Table 135. Kowa Pharmaceuticals America Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 136. Kowa Pharmaceuticals America Recent Development
    Table 137. Winston Pharmaceuticals Company Details
    Table 138. Winston Pharmaceuticals Business Overview
    Table 139. Winston Pharmaceuticals Migraine Therapeutics Product
    Table 140. Winston Pharmaceuticals Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 141. Winston Pharmaceuticals Recent Development
    Table 142. AstraZeneca Company Details
    Table 143. AstraZeneca Business Overview
    Table 144. AstraZeneca Migraine Therapeutics Product
    Table 145. AstraZeneca Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 146. AstraZeneca Recent Development
    Table 147. Amirall Company Details
    Table 148. Amirall Business Overview
    Table 149. Amirall Migraine Therapeutics Product
    Table 150. Amirall Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 151. Amirall Recent Development
    Table 152. OptiNose Company Details
    Table 153. OptiNose Business Overview
    Table 154. OptiNose Migraine Therapeutics Product
    Table 155. OptiNose Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 156. OptiNose Recent Development
    Table 157. Revance Therapeutics Company Details
    Table 158. Revance Therapeutics Business Overview
    Table 159. Revance Therapeutics Migraine Therapeutics Product
    Table 160. Revance Therapeutics Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 161. Revance Therapeutics Recent Development
    Table 162. RedHill Biopharma Company Details
    Table 163. RedHill Biopharma Business Overview
    Table 164. RedHill Biopharma Migraine Therapeutics Product
    Table 165. RedHill Biopharma Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 166. RedHill Biopharma Recent Development
    Table 167. Bausch Health Company Details
    Table 168. Bausch Health Business Overview
    Table 169. Bausch Health Migraine Therapeutics Product
    Table 170. Bausch Health Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 171. Bausch Health Recent Development
    Table 172. NeurAxon Company Details
    Table 173. NeurAxon Business Overview
    Table 174. NeurAxon Migraine Therapeutics Product
    Table 175. NeurAxon Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 176. NeurAxon Recent Development
    Table 177. Biohaven Pharma Company Details
    Table 178. Biohaven Pharma Business Overview
    Table 179. Biohaven Pharma Migraine TherapeuticsProduct
    Table 180. Biohaven Pharma Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 181. Biohaven Pharma Recent Development
    Table 182. Eisai Company Details
    Table 183. Eisai Business Overview
    Table 184. Eisai Migraine Therapeutics Product
    Table 185. Eisai Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 186. Eisai Recent Development
    Table 187. Valeant Pharma Company Details
    Table 188. Valeant Pharma Business Overview
    Table 189. Valeant Pharma Migraine Therapeutics Product
    Table 190. Valeant Pharma Revenue in Migraine Therapeutics Business (2016-2021) & (US$ Million)
    Table 191. Valeant Pharma Recent Development
    Table 192. Research Programs/Design for This Report
    Table 193. Key Data Information from Secondary Sources
    Table 194. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Migraine Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. Specific Anti-migraine Drugs Features
    Figure 3. Acute Therapies Features
    Figure 4. Preventative Therapies Features
    Figure 5. Other Features
    Figure 6. Global Migraine Therapeutics Market Share by Application: 2020 VS 2027
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Household Use Case Studies
    Figure 10. Others Case Studies
    Figure 11. Migraine Therapeutics Report Years Considered
    Figure 12. Global Migraine Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Migraine Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Migraine Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 15. Global Migraine Therapeutics Market Share by Regions (2022-2027)
    Figure 16. Global Migraine Therapeutics Market Share by Players in 2020
    Figure 17. Global Top Migraine Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Migraine Therapeutics as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Migraine Therapeutics Revenue in 2020
    Figure 19. Global Migraine Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 20. Global Migraine Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 21. North America Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Migraine Therapeutics Market Share by Type (2016-2027)
    Figure 23. North America Migraine Therapeutics Market Share by Application (2016-2027)
    Figure 24. North America Migraine Therapeutics Market Share by Country (2016-2027)
    Figure 25. United States Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Migraine Therapeutics Market Share by Type (2016-2027)
    Figure 29. Europe Migraine Therapeutics Market Share by Application (2016-2027)
    Figure 30. Europe Migraine Therapeutics Market Share by Country (2016-2027)
    Figure 31. Germany Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Migraine Therapeutics Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Migraine Therapeutics Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Migraine Therapeutics Market Share by Region (2016-2027)
    Figure 41. China Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Migraine Therapeutics Market Share by Type (2016-2027)
    Figure 49. Latin America Migraine Therapeutics Market Share by Application (2016-2027)
    Figure 50. Latin America Migraine Therapeutics Market Share by Country (2016-2027)
    Figure 51. Mexico Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Migraine Therapeutics Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Migraine Therapeutics Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Migraine Therapeutics Market Share by Country (2016-2027)
    Figure 57. Turkey Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Migraine Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Allergan Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 61. Merck Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 62. Pfizer Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 63. Teva Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 64. Amgen Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 65. Johnson & Johnson Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 66. Endo International Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 67. GlaxoSmithKline Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 68. Impax Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 69. Abbott Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 70. Bayer Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 71. Eli Lilly Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 72. Novartis International Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 73. Ethypharm Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 74. Kowa Pharmaceuticals America Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 75. Winston Pharmaceuticals Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 76. AstraZeneca Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 77. Amirall Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 78. OptiNose Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 79. Revance Therapeutics Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 80. RedHill Biopharma Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 81. Bausch Health Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 82. NeurAxon Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 83. Biohaven Pharma Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 84. Eisai Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 85. Valeant Pharma Revenue Growth Rate in Migraine Therapeutics Business (2016-2021)
    Figure 86. Bottom-up and Top-down Approaches for This Report
    Figure 87. Data Triangulation
    Figure 88. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Allergan
Merck
Pfizer
Teva
Amgen
Johnson & Johnson
Endo International
GlaxoSmithKline
Impax
Abbott
Bayer
Eli Lilly
Novartis International
Ethypharm
Kowa Pharmaceuticals America
Winston Pharmaceuticals
AstraZeneca
Amirall
OptiNose
Revance Therapeutics
RedHill Biopharma
Bausch Health
NeurAxon
Biohaven Pharma
Eisai
Valeant Pharma
Frequently Asked Questions
Migraine Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Migraine Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Migraine Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports